Clinical trial
Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction
NCT00220571 is registered in ClinicalTrials.gov with Società Italiana di Cardiologia Invasiva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction
- Lead sponsor
- Società Italiana di Cardiologia Invasiva
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2003
- Completion date
- March 31, 2007
- Enrollment
- 600 (actual)
- Sites
- 85
Conditions
As the registry lists them; a condition with its own page is linked.